“…Active pharmaceutical ingredients (APIs) might have a variety of solid forms, including polymorphs, solvates, cocrystals, salts, and amorphous forms . API molecules in different solid forms may adopt different conformations or spatial configurations, resulting in different fundamental physical properties, such as Gibbs free energy, solubility, melting point, density, stability, shape, color, etc. − Differences in these properties for different solid forms may further lead to significant differences in pharmaceutical properties of the same API, such as dissolution, bioavailability, tabletability, and flowability. − Moreover, these different solid forms can also undergo unidirectional or bidirectional transformation under certain conditions (temperature, pressure, humidity, solvent environment, etc. ), which may result in the failure of the drug or even toxic side effects. ,,− Therefore, it is important to study and master the transformation process of solid forms of APIs in detail during drug development, production, and transportation.…”